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a  b  s  t  r  a  c  t
Ethanol-mediated  free radical  generation  is directly  involved  in alcoholic  liver  disease.
In  addition,  chronic  alcohol  bingeing  also  induces  pathological  changes  and dysfunc-
tion  in multi-organs.  In  the  present  study,  the  protective  effect  of  xanthohumol  (XN)
on ethanol-induced  damage  was  evaluated  by  determining  antioxidative  parameters  and
stress oxidative  markers  in  liver,  kidney,  lung,  heart  and  brain  of rats.  An  acute  treatment
(4  g/kg  b.w.)  of ethanol  resulted  in  the  depletion  of superoxide  dismutase,  catalase  and
glutathione  S-transferase  activities  and  reduced  glutathione  content.  This  effect  was  accom-
panied by the increased  activity  of  tissue  damage  marker  enzymes  (glutamate  oxaloacetate
transaminase,  glutamate  pyruvate  transaminase  and  lactate  dehydrogenase)  and a signif-
icant increase  in  lipid  peroxidation  and  hydrogen  peroxide  concentrations.  Pre-treatmentSerum  enzymes
Stress  oxidative
with  XN protected  rat tissues  from  ethanol-induced  oxidative  imbalance  and partially
mitigated  the  levels  to  nearly  normal  levels  in  all tissues  checked.  This  effect  was  dose
dependent,  suggesting  that  XN  reduces  stress  oxidative  and  protects  rat  tissues  from
alcohol-induced  injury.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  B
1. Introduction
The prolonged consumption or large intake of alcohol
in  a short period of time causes alcoholic liver disease
(ALD), a process that involves oxidative stress and a signif-
icant  increase in the production of reactive oxygen species
(ROS)  [1]. Ethanol is metabolised by oxidative and non-
oxidative pathways, and liver alcohol dehydrogenase is
involved  in the oxidative pathway. This enzyme converts
ethanol to acetaldehyde, which, in turn, is oxidised into
acetate  by aldehyde dehydrogenase [2]. Xanthine oxidase,
the  main source of anion superoxide, is activated in this
process. Ethanol also may  be oxidised to acetaldehyde by
∗ Corresponding author. Tel.: +34 924389419.
E-mail address: pedrom@unex.es (P. Macías).
http://dx.doi.org/10.1016/j.toxrep.2014.09.004
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. Th
(http://creativecommons.org/licenses/by-nc-nd/3.0/).D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
the hepatic ethanol inducible cytochrome P450 system
(CYP2E1), resulting in the production of ROS [3]. Further-
more, acetaldehyde oxidation by xanthine oxidase and
aldehyde oxidase produces acetyl radicals that react with
proteins, nucleic acids and lipids. Due to its easy diffusion
through biological membranes, lipid peroxidation prod-
ucts  are responsible for most of the pathologies related to
oxidative  stress. Although the adverse effects of ethanol are
produced  in the liver, various other tissues are also affected,
but  to a lesser and variable degree [2,4,5].
A system of antioxidant enzymes, including super-
oxide dismutase (SOD), catalase (CAT) and glutathione
S-transferase (GST), in conjunction with a non-enzymatic
antioxidant system constituted by reduced glutathione,
vitamin E and a broad range of antioxidant agents, such
as  ﬂavonoids and phenolics, protect the cell from oxida-
tive  stress [6]. Alcohol treatment is known to deplete
is is an open access article under the CC BY-NC-ND license
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ntioxidant enzymes and decrease the concentration of
educed glutathione. These effects are accompanied by an
ncrease  in the malondialdehyde and hydrogen peroxide
oncentrations [7].
Based  on its antioxidant properties, a broad range of
ctive compounds from plants has been recently studied as
otential  agents against alcohol-induced pathogenesis. The
eneﬁcial  effects against ethanol intoxication are report-
dly  attributed to the regulation of pathways involved in
xidation,  inﬂammation and lipid metabolism, although
he  mechanisms of action of these compounds remain
o  be elucidated [8]. Xanthohumol (XN), a hop-derived
renylated ﬂavonoid, was identiﬁed among these com-
ounds. The hop plant (Humulus lupulus L.) is a dioecious
lant of the Cannabacea family that is cultivated for its
emale  inﬂorescences. Hops are used in the brewing indus-
ry  to add ﬂavour, aroma, bitterness and stability to beer.
n  vitro studies have revealed that XN possesses various bio-
ogical  properties, such as antioxidant, anti-inﬂammatory
nd anticancer activities, suggesting a potential chemo-
reventive effect [9–11]. Metabolisation studies have
hown that the XN molecule remains unchanged and that
he  antioxidant capacity measured in vitro is 8.9 times
igher than that of trolox [12]. However, this compound
as not yet been sufﬁciently evaluated in vivo.
In previous studies, we reported that XN prevents acute
iver  injury induced in rats by a treatment with carbon
etrachloride [13]. This model in vivo assay has frequently
een used to evaluate the antioxidant efﬁciency of natu-
al  compounds, given that the toxic process has been well
stablished to be mediated by the trichloromethyl free rad-
cal  (•CCl3) and trichloromethyl peroxy radical (Cl3COO•)
13,14].  Although this model provides valuable information
bout the in vivo antioxidant efﬁciency of natural com-
ounds, CCl4-induced hepatotoxicity is not a general model
f  liver damage, and alternative models consequently need
o  be used to more effectively assess the antioxidant prop-
rties.  Thus, the used the ALD as model of hepatotoxicity
nd multi-organ dysfunction, which can provide valuable
nformation complementary to that obtained from a CCl4-
nduced  model of injury.
In  this study we used a model of acute ethanol toxicity
o  determine the protective efﬁciency of XN on the antiox-
dant  defence systems in the liver, kidney, lung, heart and
rain  for a pathological status close to that produced in
umans  an ethylic intoxication.
.  Materials and methods
.1.  Chemicals
Xanthohumol (96%) and all chemicals required for the
iochemical assays were obtained from Sigma–Aldrich
uimica (Madrid, Spain). All other chemicals were of ana-
ytical  grade.
.2.  Animals and experimental designMale Wistar rats (200–250 g, 4 months of age) were
aintained at standard environmental conditions: 22 ◦C
ith  a 12 h light/dark cycle, controlled humidity and airrts 1 (2014) 726–733 727
circulation with free access to food and water. All the exper-
iments  were carried out between 9:00 and 17:00 h and, in
all  cases, samples were collected at 10:00 h. The appropri-
ate  guidelines of the local animal ethics committee were
followed throughout all animal experiments.
Rats were randomly divided into 8 groups with 6 ani-
mals  per group. In all cases, an orogastric tube was used
to  treat rats with vehicle or XN. Group I was  the nor-
mal  control and was given vehicle alone (1,2-propanodiol,
2 mL/kg b.w. per day for 7 days). Group II was treated the
same  as Group I, but a 4.0 g/kg b.w. dose of EtOH (30% dilu-
tion)  was i.p. injected into each animal on the 7th day.
Groups III, IV and V were treated with Xanthohumol dis-
solved  in 1,2-propanodiol at dose levels of 0.1, 0.2 and
0.4  mg/kg b.w., respectively, per day for 7 days, and a single
dose  of 4.0 g/kg b.w. EtOH (in a 30% solution) was admin-
istered i.p. on the 7th day. The range of doses used in
this  work was  established as part of a previous study of
the  effect of XN using a wider range of concentrations
(data not shown). Groups IIIc, IVc and Vc were the controls
for  Groups III, IV and V and consisted of rats pre-treated
with the same XN concentrations that did not receive an
EtOH  injection. With the aim to check if the injection
causes some alteration of measurements, as consequence
of the stress induced in the animal, controls IIIc, IVc and
Vc  also were carried out with an injection of saline solu-
tion,  but no signiﬁcant differences were detected when
compared with rats that not received injection. After 12 h,
each  rat was anesthetised by chloroform inhalation in order
to  draw blood and remove the tissues. The blood sam-
ples  were collected by cardiac puncture and allowed to
clot  for 45 min  at room temperature. The serum was sepa-
rated  by centrifugation at 600× g for 15 min  and analysed
for glutamate oxaloacetate transaminase (GOT), glutamate
pyruvate transaminase (GPT) and lactate dehydrogenase
(LDH). The liver, kidney, lung, heart and brain were excised,
homogenised and assayed for reduced glutathione (GSH),
thiobarbituric acid reactive substances (TBARS) and H2O2
levels, as well as for the catalase (CAT), superoxide dis-
mutase (SOD) and glutathione S-transferase (GST) enzyme
activities according to the procedures described below.
2.3.  Tissues homogenate preparation
After removal, the liver, kidney, lung, heart and brain
were homogenised in a solution of 10 mM KCl, 1 mM EDTA
and  100 mM phosphate buffer at pH 7.4. The homogenate
was centrifuged at 12,000× g for 60 min. The supernatant
was used as a source to assay the enzymatic markers of
oxidative stress, including the SOD, CAT and GST activities.
The  GSH, TBARS, H2O2 and total protein content were also
determined.
2.4.  Determination of serum transaminases GOT and GPT
activities
Serum  GOT and GPT activities were determined
using a procedure previously described by Bergmeyer
and Holder [15,16]. The reaction mixture to mea-
sure the GOT activity contained 290 mM l-aspartate
(600 mM l-alanine for measurement of GPT activity),
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15 mM -ketoglutarate, 0.26 mM NADH, 368 U/L of malate
dehydrogenase (1080 U/L of lactate dehydrogenase for
measurement of GPT activity) and 100 mM Tris–HCl at pH
7.8  in a ﬁnal volume of 1 mL.  Enzymatic activity was calcu-
lated  based on the change in absorbance at 340 nm and is
expressed  as mol/min/mg protein.
2.5. Determination of serum lactate dehydrogenase
activity (LDH)
LDH  activity was measured in serum using the proce-
dure described by Kornberg [17]. A total of 100 L of serum
was  incubated in the presence of 100 L of 20 mM NADH
and  100 L of 10 mM sodium pyruvate in 100 mM sodium
phosphate buffer at pH 7.4 and brought to a ﬁnal volume of
3  mL.  The change in the absorbance was continuously mon-
itored  at 340 nm,  and the enzyme activity was calculated
using a molar extinction coefﬁcient of 6220 M−1 cm−1 and
expressed as nmol NAD+/min/mg protein.
2.6. Determination of the level of lipid peroxidation
Malonyldialdehyde (MDA) is an end product of lipid
peroxidation that reacts with thiobarbituric acid to form
a  pink chromogen-thiobarbituric acid reactive substance
(TBARS). The level of this compound was measured using
a  procedure previously described by Ohkawa et al. [18].
The  TBARS was  prepared by mixing equal volumes of 15%
trichloroacetic acid and a solution of 15% 2-thiobarbituric
acid in 0.25 M HCl. Two volumes of this reactive solution
were added to a volume of sample, and the mixture was vig-
orously  vortexed. Subsequently, this solution was  heated to
100 ◦C for 20 min, cooled and centrifuged at 10,000× g for
15  min. The supernatant was separated and spectrophoto-
metrically measured at 532 nm.  The absorbance value is
proportional to the amount of MDA  formed and was cal-
ibrated  to known concentrations of MDA  ranging from 0
to  3.3 M.  The results are expressed as nmol of MDA/mg
protein.
2.7. Determination of hydrogen peroxide
Hydrogen peroxide generation was analysed using the
procedure of Pick and Keisari [19]. The reaction mix-
ture  contained the sample in addition to 180 units of
horseradish peroxidase, 3.5 M phenol red, 0.370 mM dex-
trose  and 50 mM phosphate buffer at pH 7.6 in a ﬁnal
volume of 1.2 mL.  The mixture was incubated for 30 min
at  37 ◦C. Subsequently, the mixture was alkalinised with
0.3  M NaOH and centrifuged at 14,000× g for 3 min. The
absorbance of the supernatant was measured at 610 nm
to  determine the hydrogen peroxide content, which is
expressed as mmol/mg  protein.
2.8. Determination of reduced glutathione (GSH)
Reduced glutathione content was measured using
the procedure described by Ellman [20]. A volume of
hepatic homogenate was mixed with a volume of 10%
trichloroacetic acid and centrifuged to separate the pro-
teins.  A total of 10 L of supernatant was added to 1 mL  ofrts 1 (2014) 726–733
100  mM phosphate buffer at pH 8.4, 0.025 mL  of 5 mM 5,5-
dithio-bis-(2-nitrobenzoic acid) and 0.165 mL  of distilled
water. The mixture was vortexed and incubated for 15 min,
and  the absorbance was subsequently measured at 412 nm.
The  concentration of reduced glutathione is expressed as
nmol  GSH/mg protein.
2.9.  Determination of superoxide dismutase (SOD)
activity
SOD activity was  measured using the method described
by  Marklund and Marklund [21]. The reaction mixture
consisted of the sample, 0.2 M pyrogallol, 1 mM EDTA and
50  mM Tris–HCl at pH 8.2 in a ﬁnal volume of 1 mL. Enzy-
matic activity was  measured by monitoring the absorbance
at  420 nm and expressed as U/mg. A unit of activity (U)
was  deﬁned as the amount of enzyme that produced a 50%
inhibition of pyrogallol auto-oxidation.
2.10. Determination of catalase (CAT) activity
CAT activity was measured using the method described
by Aebi [22]. The reaction mixture contained the sam-
ple,  10 mM H2O2 and 50 mM phosphate buffer at pH 7.0
in  a ﬁnal volume of 1 mL.  The rate of decomposition
of H2O2 was measured at 240 nm,  and catalase activity
is expressed as nmol H2O2 decomposed/min/mg pro-
tein  using an extinction coefﬁcient of 32.54 M−1 cm−1 for
hydrogen peroxide.
2.11.  Determination of glutathione S-transferase (GST)
activity
GST  activity was measured according to Habig et al. [23].
The  reaction mixture contained sample, 0.1 mL  of 1 mM
GSH,  20 L of 50 mM 1-chloro-2,4-dinitrobenzene (CDNB)
and  0.1 M phosphate buffer at pH 6.5 in a ﬁnal volume of
3.0  mL.  Enzyme activity was measured based on the change
in  the absorbance at 340 nm using a molar extinction coefﬁ-
cient  of 9.6 M−1 cm−1 and expressed as nmol CDNB–GSH
conjugate formed/min/mg protein.
2.12. Determination of protein concentration
Protein concentration was  measured using the method
described by Lowry et al. [24] with bovine serum albumin
as  a standard.
2.13. Statistical analysis
Data  were expressed as mean ± standard deviation (SD)
and  p-values were considered signiﬁcant for p < 0.05. Dif-
ferences  within the experimental groups were established
by  one or two-way analysis of variance (ANOVA) followed
by  F-Fisher post hoc test when appropriate. All tests were
executed using the SPSS statistical software (version 19).3.  Results and discussion
The  aim of this study was to evaluate the efﬁciency of
XN  as a protective agent against oxidative damage induced
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Table 1
Effect of xanthohumol on serum GOT, GPT and LDH activities.
GOT
mol/min/mg
protein
GPT
mol/min/mg
protein
LDH
mol/min/mg
protein
Control (Group I) 5.91 ± 0.23 2.95 ± 0.11 1.37 ± 2.03
EtOH  (Group II) 12.53 ± 0.61* 5.32 ± 0.22* 2.03 ± 0.11*
XN 0.1 + EtOH (Group III) 9.51 ± 0.35*,# 4.63 ± 0.19*,# 2.02 ± 0.09*
XN 0.2 + EtOH (Group IV) 6.89 ± 0.21*,# 3.52 ± 0.17*,# 1.75 ± 0.08*,#
XN 0.4 + EtOH (Group V) 6.05 ± 0.19# 3.11 ± 0.15# 1.45 ± 0.08*,#
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Dach value represents the mean ± SD (n = 6).
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05).
n rat tissues after acute intoxication due to ethanol admin-
stration. Our experimental design is based on previous
tudies in which acute ethanol-induced oxidative damage
onstituted a valid procedure to determine the protective
ffect of compounds of therapeutic interest [25–27].
The mechanisms of intoxication for acute and chronic
lcohol treatment are known to differ. For instance, Yang
t  al. [34] reported that although CYP2E1 plays a major
ole  in chronic ethanol-induced oxidative stress, the initial
xidative process for acute alcohol treatment is indepen-
ent of CYP2E1. In addition, the effect of ethanol in the
ardiovascular system reportedly depends on the pattern
f  ethanol drinking, i.e., acute or chronic. While chronic
thanol intake induces hypertension, acute treatment
nduces hypotension, which suggests different mecha-
isms of action [28].
The  experimental conditions used in the present study
oincided with a binge-drinking model. This model, based
n  the ethanol administration via i.p. injection, was
esigned to achieve blood ethanol levels, behavioural
ffects and physiological changes comparable to those
bserved in human binge drinking and has been used to
valuate  the effect of ethanol in various tissues, such as
iver  [25,29–31], brain [32,33], lung, kidney [27] and vascu-
ar  tissues [28]. Acute ethanol intake was shown to produce
xidative stress in all cases.
Despite  the considerable interest in the binge ethanol
reatment of rats because this approach mimics human
inge drinking, the number of studies that have evaluated
ntioxidant protective efﬁciency of natural compounds
sing this assay model are limited.
The dose of ethanol used in this study was based on
revious studies [25,32,34–36], and our preliminary exper-
ments  (data not shown).
To  evaluate the in vivo protective efﬁciency of XN, we
xamined the effect of XN pre-treatment on the response
able 2
ffect of ethanol administration and xanthohumol treatment on TBARS (nmol MD
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Gr
Liver 0.115 ± 0.006a 0.771 ± 0.038*,a 0.513 ± 0.021*,#,
Kidney 0.334 ± 0.015b 0.972 ± 0.047*,b 0.662 ± 0.029*,#,
Lung 0.243 ± 0.011c 0.377 ± 0.018*,c 0.361 ± 0.016*,#,
Heart 0.251 ± 0.012c 0.285 ± 0.014*,d 0.271 ± 0.013*,#,
Brain 0.654 ± 0.031d 0.702 ± 0.031*,a 0.660 ± 0.032*,#,
ach value represents the mean ± SD (n = 6).
ifferent  letters in the same column represent statistically signiﬁcant differences
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05).of  the antioxidant defence system and the level of oxidative
stress in various rat tissues after acute ethanol consump-
tion. A dose of 4.0 g/kg b.w. EtOH produced a peak blood
concentration of 0.4%, which did not affect the survival of
rats.  The effect of this acute treatment on GOT, GPT and LDH
is  shown in Table 1.
The  serum GOT, GPT and LDH of binge ethanol-treated
rats were signiﬁcantly elevated compared to the con-
trol  (p < 0.05); increases of 212% for GOT, 180% for GPT
and  148% for LDH were estimated. These data reveal that
binge  alcohol treatment resulted in cellular damage in the
liver,  although the membrane permeability of other tis-
sues  may  have also changed as consequence of the effect
of  ROS generated during ethanol metabolism. The pro-
tective effect of the XN pre-treatment was  signiﬁcant for
the  dose-dependent normalisation of the serum GOT, GPT
and  LDH activities compared to the ethanol only-treated
group. Notably, XN alone did not produce signiﬁcant effects
compared to the control (groups IIIc, IVc and Vc, data not
shown); however, XN pre-treatment at 0.4 mg  XN/kg b.w.
protected GOT, GPT and LDH activities by 97.8%, 93.2% and
87.9%,  respectively, compared to control rats. Table 1 shows
the  clear dose-dependent protective effect of XN against
cellular damage produced by ROS.
The above data are consistent with the observed effect
of  ethanol and XN pre-treatment on lipid peroxidation.
Table 2 shows a 6.7-fold increase in the level of lipid per-
oxidation of livers stressed by ethanol. This effect does not
quantitatively coincide with the other assayed tissues. The
lipid  peroxidation in the liver increased approximately 3-
fold  over the value of the control, but the increase was  only
50%,  13% and 7% for lung, heart and brain, respectively.
This signiﬁcant increase in liver lipid peroxidation when
compared with other tissues has been previously reported,
being  supported by the fact that nearly 60–80% of ingested
alcohol is metabolised in the liver, which makes this organ
A/mg protein) concentration in different rat tissues.
oup III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
a 0.365 ± 0.018*,#,a 0.211 ± 0.011*,#,a
b 0.483 ± 0.022*,#,b 0.398 ± 0.019*,#,b
c 0.322 ± 0.015*,#,a 0.323 ± 0.016*,#,c
d 0.265 ± 0.013*,#,c 0.253 ± 0.014#,d
b 0.658 ± 0.008*,#,d 0.655 ± 0.032#,e
 (p < 0.05).
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Table  3
Effect  of ethanol administration and xanthohumol treatment on H2O2 concentration (mmol/mg protein) in different rat tissues.
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Group III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
Liver 0.48 ± 0.02a 1.32 ± 0.06*,a 1.18 ± 0.05*,#,a 0.75 ± 0.03*,#,a 0.61 ± 0.03*,#,a
Kidney 0.98 ± 0.04b 1.66 ± 0.07*,b 1.41 ± 0.07*,#,b 1.09 ± 0.05*,#,b 1.05 ± 1.05*,#,b
Lung 1.38 ± 0.05c 3.00 ± 0.12*,c 2.21 ± 0.11*,#,c 2.19 ± 0.11*,#,c 2.05 ± 0.11*,#,c
Heart 1.75 ± 0.08d 1.79 ± 0.07*,b 1.78 ± 0.06*,d 1.77 ± 0.07*,#,d 1.75 ± 0.06#,d
Brain 1.27 ± 0.05c 1.32 ± 0.05*,a 1.28 ± 0.05*,#,a 1.28 ± 0.06*,#,e 1.27 ± 0.06#,e
Each value represents the mean ± SD (n = 6).
ferencesDifferent  letters in the same column represent statistically signiﬁcant dif
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05).
more vulnerable than others to alcohol-induced oxidative
stress [37]. Furthermore, the presence of a high concentra-
tion of oxidisable fatty acids and iron in liver signiﬁcantly
contributes to ROS production. Similarly, oxidative stress
also  signiﬁcantly affects the kidney because it is involved in
the  excretion of metabolised products [38]. Pre-treatment
with low (0.1 mg/kg b.w.) or high (0.4 mg/kg b.w.) doses of
XN  signiﬁcantly decreased the level of lipid peroxidation.
A low XN dose decreased lipid peroxidation level by 33.5%
in  liver, 31.9% in kidney, 4.2% in lung, 4.9% in heart and 7.4%
in  brain compared with the controls, which lacked XN pre-
treatment. Pre-treatment with a high dose of XN decreased
the  level of peroxidation, by 72.6% in liver and 50.05% in
kidney,  but this decrease was only 14.4% lung, 0.7% in heart
and  7.2% in brain. These results suggest that pre-treatment
with XN strongly reduces lipid peroxidation in tissues more
affected  by ROS, because the effect was not signiﬁcant in
tissues  (lung, heart and brain) where the oxidative changes
were  small. The effect of binge ethanol treatment on the
generation of hydrogen peroxide was studied to conﬁrm
this  point.
Acute and chronic alcohol exposure are well docu-
mented to increase the generation of ROS, given that
hydrogen peroxide one of the main compounds responsi-
ble  for the generation of oxidative stress in many tissues.
Hydrogen peroxide can be generated as a by-product of
EtOH  oxidation by Cyt P450 and alcohol dehydrogenase
because this peroxide is speciﬁcally and directly involved
in  EtOH cytotoxicity [8].
Our results (Table 3) clearly show that binge ethanol
treatment increased hydrogen peroxide concentration by
a  factor of 2.75 in liver, 1.69 in kidney and 2.17, in lung;
the  hydrogen peroxide generation was negligible in heart
and  brain. These results ﬁt well with the observed effects
of  binge EtOH treatment on lipid peroxidation, suggesting
that the oxidative stress is more relevant only in tissues
Table 4
Effect  of ethanol administration and xanthohumol treatment on GSH concentrati
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Gr
Liver 18.831 ± 1.38a 6.053 ± 0.220*,a 6.410 ± 0.315*,#,
Kidney 9.445 ± 0.482b 5.271 ± 0.262*,b 5.662 ± 0.251*,#,
Lung 1.088 ± 0.104c 0.746 ± 0.029*,c 0.748 ± 0.035*,c
Heart 1.127 ± 0.078c 0.751 ± 0.030*,c 0.750 ± 0.037*,c
Brain 3.761 ± 0.225d 3.293 ± 0.161*,d 3.296 ± 0.164*,d
Each value represents the mean ± SD (n = 6).
Different  letters in the same column represent statistically signiﬁcant differences
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05). (p < 0.05).
where the EtOH metabolisation is more intense. The efﬁ-
ciency  of XN pre-treatment is manifested by a signiﬁcant
dose-dependent decrease in the hydrogen peroxide con-
centrations in liver, kidney and lung, while the changes in
heart  and brain were unremarkable.
In  addition to the increased concentration of ROS  pro-
duced by EtOH intoxication alcohol-related diseases are
known  to deplete GSH. This thiol plays a pivotal role in the
defence  mechanisms against ROS, reacting directly with
oxygen  radicals and electrophilic metabolites to protect
essential thiol groups against oxidation, which act as a
substrate for GSH-related enzymes involved in antioxida-
tive defence processes. Table 4 shows that acute EtOH
administration produces a relevant decrease in the GSH
concentration in liver (near 68%), kidney (44%), lung (31%),
heart  (33%) and brain (12%). The pre-treatment of rats
with  XN protect, in a dose-dependent manner, against
GSH depletion induced by acute EtOH administration. The
level  of GSH concentration in livers of rats pre-treated
with a dose of 0.4 mg/kg b.w. reaches 91.2% of the con-
trol  level in the absence of EtOH. The level of protection
reached values near 90% for kidney and lung, but the
depletion of GSH was very small in these cases, and the
protective effect of XN is less relevant that in liver. The
marked decrease in liver GSH of rats treated with EtOH and
the  signiﬁcant differences among the GSH level in differ-
ent  tissues coincides with previously reported studies in
rats  receiving chronic ethanol treatment [39]. The intense
GSH  depletion in liver compared to other tissues may  be
explained by the high rate of hepatic EtOH metabolisation,
which depletes GSH by damaging the inner mitochondrial
membrane [40]. Our result shows that XN partially pre-
vents  ethanol-induced GSH depletion in a dose-dependent
manner.
SOD catalyses the decomposition of superoxide into
hydrogen peroxide and water, making it one of the more
on (nmol/mg protein) in different rat tissues.
oup III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
a 10.185 ± 0.478*,#,a 17.184 ± 0.851*,#,a
b 6.541 ± 0.315*,#,b 7.809 ± 0.350*,#,b
0.776 ± 0.033*,#,c 0.976 ± 0.035*,#,c
1.011 ± 0.047*,#,d 1.026 ± 0.051#,c
3.504 ± 0.157*,#,e 3.358 ± 0.155*,#,d
 (p < 0.05).
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Table 5
Effect of ethanol administration and xanthohumol treatment on SUPEROXIDE DISMUTASE activity (U/mg protein) in different rat tissues.
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Group III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
Liver 25.06 ± 1.21a 6.66 ± 0.29*,a 12.52 ± 0.58*,#,a 16.65 ± 0.81*,#,a 20.14 ± 0.98*,#,a
Kidney 11.12 ± 0.51b 4.48 ± 0.21*,b 5.41 ± 0.21*,#,b 5.74 ± 0.21*,#,b 8.33 ± 0.25*,#,b
Lung 4.52 ± 0.22c 2.39 ± 0.11*,c 2.54 ± 0.12*,#,c 3.32 ± 0.15*,#,c 4.16 ± 0.16*,#,c
Heart 3.70 ± 0.18d 1.61 ± 0.08*,d 1.92 ± 0.11*,#,d 2.56 ± 0.11*,#,d 2.94 ± 0.11*,#,d
Brain 3.57 ± 0.17d 2.45 ± 0.11*,c 2.77 ± 0.14*,#,c 2.89 ± 0.13*,#,d 3.19 ± 0.12*,#,d
Each value represents the mean ± SD (n = 6).
Different  letters in the same column represent statistically signiﬁcant differences (p < 0.05).
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05).
Table 6
Effect of ethanol administration and xanthohumol treatment on CATALASE activity (nmol H2O2 decomposed/min/mg protein) in different rat tissues.
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Group III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
Liver 469.2 ± 19.2a 225.5 ± 10.27*,a 272.3 ± 13.32*,#,a 303.2 ± 13.12*,#,a 379.5 ± 17.23*,#,a
Kidney 215.5 ± 9.32b 128.7 ± 5.43*,b 145.5 ± 6.98*,#,b 180.2 ± 8.98*,#,b 194.5 ± 8.25*,#,b
Lung 27.8 ± 1.11c 19.4 ± 0.77*,c 20.1 ± 0.85*,#,c 27.5 ± 1.31#,c 28.0 ± 1.22#,c
Heart 25.5 ± 1.21c 13.2 ± 0.66*,d 17.6 ± 0.81*,#,d 21.2 ± 0.88*,#,d 24.3 ± 1.02#,d
Brain 6.5 ± 0.29d 7.1 ± 0.32*,e 7.0 ± 0.25*,d 6.8 ± 0.29*,#,e 6.5 ± 0.23#,e
Each value represents the mean ± SD (n = 6).
D ferences
r
b
a
e
h
i
O
n
k
i
o
T
o
[
o
r
t
i
X
u
7
t
m
T
E
i
E
Different  letters in the same column represent statistically signiﬁcant dif
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05).
elevant regulators of ROS concentration. SOD is known to
e  inactivated by prolonged ethanol administration, and
lthough  it has been studied in several organs, the liver
nzyme is more strongly inactivated. Acute ethanol intake
as  also been reported to signiﬁcantly decrease SOD activ-
ty  in brain [32,33], liver [29,25,30], lung and kidney [27].
ur  data (Table 5) show that binge ethanol intake sig-
iﬁcantly decreased the SOD activity in liver by 73.5%, in
idney  by 59.7%, in lung by 47.8%, in heart by 56.5% and
n  brain by 31.4% compared with normal control. The level
f  inactivation of liver SOD is higher than in other organs.
his  observation coincides with the results obtained by
ther  authors using a model of chronic ethanol intake
41]. Although SOD activity is enhanced in the presence
f  a low concentration of ROS, the overproduction of free
adicals  during EtOH intoxication results in enzyme inac-
ivation  [42]. The pre-treatment with XN prevented this
nactivation in a dose-dependent manner: a dose of 0.4 mg
N/kg  b.w. signiﬁcantly increased the SOD activity to val-
es  of 80.36% in liver, 74.6% in kidney, 92.03% in the lung,
9.45%  in the heart and 89.35% in the brain compared with
he  controls in the absence of EtOH treatment. This effect
ay  be mediated by the direct interaction of EtOH or by
able 7
ffect of ethanol administration and xanthohumol treatment on glutathione S-tr
n  different rat tissues.
Control (Group I) EtOH (Group II) 0.1 XN + EtOH (Gr
Liver 0.416 ± 0.019a 0.197 ± 0.009*,a 0.215 ± 0.011*,#,
Kidney 0.068 ± 0.003b 0.028 ± 0.001*,b 0.035 ± 0.001*,#,
Lung 0.041 ± 0.002c 0.017 ± 0.001*,c 0.021 ± 0.001*,#,
Heart 0.082 ± 0.004d 0.006 ± 0.0003*,d 0.008 ± 0.0003*,#
Brain 0.022 ± 0.001e 0.018 ± 0.001*,c 0.019 ± 0.001*,c
ach value represents the mean ± SD (n = 6).
ifferent  letters in the same column represent statistically signiﬁcant differences
* Signiﬁcantly different from control (p < 0.05).
# Signiﬁcantly different from EtOH treated rats (p < 0.05). (p < 0.05).
an  indirect process mediated by acetaldehyde from EtOH
metabolisation [43].
At  physiological conditions, SOD and CAT act synergis-
tically to ﬁne-tune the ROS levels. Our results in Table 6
reveal  that the inhibitory effect of EtOH on CAT activity
and the protection of XN from this inhibition are similar
to  those observed for SOD. Furthermore, the activity levels
for  each tissue studied are coincident for both enzymes, and
the  high levels of activity in liver and kidney are remark-
able. CAT activity measured in rats pre-treated with 0.4 mg
XN/kg  b.w. reached 80.8% in liver, 90.2% in kidney, 99.2%
in  lung, 95.3% in heart and 89.3% in brain compared to
the  controls, evidencing the high efﬁciency with which XN
protected  cells from acute EtOH intoxication.
Finally, we  measured the glutathione S-transferase
(GST) activity in tissues. This enzyme is involved in ROS
elimination together with SOD and CAT. Plant extracts
with antioxidant properties have been reported to up-
regulate GST in rats [8]. GST is also involved in the ethanol
detoxiﬁcation process; the GST activity was shown to be
signiﬁcantly lower in mouse primary hepatocytes after
ethanol exposure [44]. Our results (Table 7) clearly demon-
strate  the protective effect of XN in all examined tissues,
ansferase activity (nmol CDNB–GSH conjugate formed/min/mg protein)
oup III) 0.2 XN + EtOH (Group IV) 0.4 XN + EtOH (Group V)
a 0.241 ± 0.011*,#,a 0.282 ± 0.014*,#,a
b 0.055 ± 0.003*,#,b 0.067 ± 0.003#,b
c 0.029 ± 0.001*,#,c 0.031 ± 0.001*,#,c
,d 0.010 ± 0.0003*,#,d 0.015 ± 0.0002*,#,d
0.021 ± 0.001#,e 0.021 ± 0.007#,e
 (p < 0.05).
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especially at a dose of 0.4 mg/kg b.w. The signiﬁcant differ-
ences  between the GST activities of tissues coincide with
previous studies [45–47] and are attributable to their dif-
ferent  metabolic roles [5].
The results presented here led us to conclude that
XN administration to rats protects against acute alcohol-
induced oxidative damage. Additionally, the fact that in
absence  of ethanol all the parameters measured in rats only
treated  with XN were coincident with control (Group I),
strongly  suggest the absence of toxicity of XN at assayed
concentration. The prevention of EtOH toxicity by XN
pre-treatment is evidenced by the inhibition of lipid per-
oxidation, the protection from tissue degradation and the
maintenance of normal values for the chemical and bio-
chemical markers of oxidative stress. In previous work [13]
we  shown from histopathological studies that XN protect
against severe hepatic necrosis induced by carbon tetra-
chloride, an alteration similar to described in liver of EtOH
intoxicated rats [29,30], suggesting that XN can exert sim-
ilar  protective effect against histopathological alteration
induced by acute administration of EtOH. However, despite
all  the information accumulated, the exact mechanism by
which  XN exerts its antioxidant effect remains unclear,
and further studies are necessary in order to implement
the therapeutic use of XN to protect tissues from ethanol-
induced oxidative injury.
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